Skip to content
WebMD: Better information. Better health.
June 21, 2012
This content is from our sponsor. The sponsor has sole editorial control.

You are an individual who is defined by more than your relapsing MS. And your experience with relapsing MS is unique.

Learn More about Rebif

By choosing Rebif, you get more than just proven efficacy—you get access to a range of services and support through MS LifeLines® that is designed to meet your individual needs.

Real People, Real Stories

The Support You Need Today, and Every Step of the Way

Meet David Meet David

David believes his optimistic attitude helps keep him in control of his own life with relapsing MS.

Meet Joni Meet Joni

Vibrant and motivated, Joni isn't going to let relapsing MS get in the way of her goals.

View Now

Watch videos about living with relapsing MS from real patients.

MS LifeLines and MS LifeLines Ambassadors are sponsored by EMD Serono, Inc. and Pfizer Inc.

Next Article:

Indication

Rebif is used to treat relapsing forms of MS to decrease the frequency of relapses and delay the occurrence of some of the physical disability that is common in people with MS. Rebif is not approved for treatment of chronic progressive MS. Rebif is available in 22 mcg and 44 mcg prefilled, preassembled syringes and a titration pack.

Important safety information

Before beginning treatment, patients should discuss with their doctor the potential benefits and risks associated with Rebif. Let your doctor know if you have a history of depression, seizures, liver disease, thyroid problems, or blood cell count or bleeding problems, or if you have had previous allergic reactions to medications. Tell your doctor about all medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements. Rebif and other medicines may affect each other causing serious side effects. Talk to your doctor before you take any new medicines. Rebif is not recommended for women who are or plan to become pregnant.

Potential serious side effects of Rebif include depression and risk of suicide, liver problems, risk to pregnancy, injection-site problems, and severe allergic reactions. Allergic reactions are rare and may be associated with difficulty in breathing and loss of consciousness, which require immediate medical attention.

The most common side effects with Rebif are injection-site reactions, flu-like symptoms (fever, chills, muscle aches, tiredness), depression, abdominal pain, elevated liver enzymes, and blood abnormalities.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

This information is not intended to replace discussions with your doctor. For additional information about Rebif, please consult the Medication Guide and talk to your doctor. You can also visit www.mslifelines.com or call toll-free 1-877-447-3243. Rebif is available by prescription only.

Rebif and MS LifeLines are registered trademarks of EMD Serono, Inc. or its affiliates.

Brought to you by EMD Serono, Inc. and Pfizer Inc, the co-marketers of
Rebif® (interferon beta-1a) in the US.
EMD Serono / Pfizer

Prescribing Information (PDF) - Medication Guide (PDF)

This information is intended only for residents of the United States.

Privacy Policy - Terms of Use